2019 - News Updates
-
CHEK2 Identified as Intermediate-risk Driver of Testicular Germ Cell Tumor Susceptibility
CHEK2 germline pathogenic variants are associated with a four-to-six times elevated risk for Testicular Germ Cell Tumors (TGCT), and an average age at presentation six years earlier than carriers of wild-type alleles.
-
Curie-NCI Collaborative Partnership Program Announces Inaugural Awardees
Three projects were selected for the inaugural Curie-NCI Collaborative Partnership Program. Each project has at least one investigator from the NCI and the Institut Curie.
-
Drug Overdose Deaths a National Problem, not Limited to Poor, Rural Counties
Researchers in the NCI Division of Cancer Epidemiology and Genetics and collaborators at the National Institutes of Health conducted a formal analysis of overall death rates and death rates from drug poisoning among 25-64-year-olds in the United States. They compared rates across race/ethnicity, socioeconomic status, rurality and geography to determine whether increases in these deaths are limited to poor, rural, white communities in regions with high unemployment.
-
Interferon Lambda Experts Meet at NIH to Discuss Disease Impact and Translational Potential
In October 2018, researchers at the National Cancer Institute hosted, “IFN Lambda: Disease Impact and Translational Potential,” a meeting of international experts to enhance interdisciplinary communication and promote new collaborations on Interferon Lambda.
-
AI Approach Outperformed Human Experts in Identifying Cervical Precancer
A research team led by investigators from NIH and Global Good has developed a computer algorithm that can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention.
-
BRCA Exchange Aggregates Data on Thousands of BRCA1 and BRCA2 Variants
BRCA Exchange is a global resource with data and expert classification on thousands of inherited variants in the BRCA1 and BRCA2 genes that will improve cancer prevention, screening, and intervention for high-risk patients.
-
Jonas Almeida Named Chief Data Scientist of DCEG
Jonas S. Almeida, Ph.D., has been appointed Chief Data Scientist in DCEG. He is internationally recognized for his work on integrative biomedical applications that combine systems biology, computational statistics, and software engineering.
-
Michele Doody, Radiation Scientist, Retires from NCI
Michele Doody, M.S., a staff scientist in the Radiation Epidemiology Branch (REB), retired at the end of December 2018 after more than 30 years of federal service. Her research focused on the role of low-dose radiation in carcinogenesis from both diagnostic and occupational exposures.
-
Myotonic Dystrophy Type I Clinical Care Recommendations Influenced by DCEG Research
New consensus-based guidelines for the clinical management of adult patients with Myotonic Dystrophy type I (DM1) were based in part on research by investigators in the Clinical Genetics Branch.
-
HPV Screening History Important for Management of New, Abnormal Results
HPV screening history of multiple negative HPV and cytology cotests important for management of current results in cervical cancer screening programs. The data come from over a million women aged 30 and older in Kaiser Permanente Northern California.